Xcimzane

Biogen and Xbrane in deal on rheumatoid arthritis targeting biosimilar
Biopharma Reporter
Mon, 02/14/22 - 11:04 am
Biogen
Xbrane Biopharma
monoclonal antibodies
Xcimzane
Cimzia
rheumatoid arthritis